This post focuses on Rocket Lab (RKLB). The core idea is that the company has recently completed a series of U.S. defense-related missions, and combined with its upcoming Electron launch schedule and progress on Neutron/Archimedes, this could create a “hot summer” trading catalyst. The OP’s text is very short, with the main evidence coming from images. The first table lists several Rocket Lab missions completed in 2026, including “The Cosmos Will See You Now” on January 22, “Daughter of the Stars” on March 28, “Viva La StriX” on May 22, HASTE “Curveball” on June 11, and “VICTUS HAZE Puma” on June 19, all marked as successful. Among them, Curveball is labeled as a U.S. Air Force hypersonic test payload, and VICTUS HAZE is labeled as a U.S. Space Force TacRS spacecraft, with the intent of emphasizing defense-customer validation and responsive-launch capability. The fourth image comes from Rocket Lab’s launch page and shows upcoming missions including Synspective’s “Ten Owl Of Ten,” iQPS’s “The Grain Goddess Provides” (NET June 2026), NASA’s Aspera, and NASA & Eta Space’s LOXSAT. From this, the OP infers that there will still be near-term launch-related news flow. The fifth image shows a Neutron overview: height 43 meters, diameter 7 meters, fairing diameter 5 meters, LEO payload 13,000 kg, liftoff mass 480,000 kg, and LOX/methane propellant, implying the company is upgrading from the small Electron rocket to a medium-lift reusable rocket. The statement in the body that “Archimedes powers Neutron by EOY” is the most aggressive view, meaning the OP believes the Archimedes engine will push Neutron into a key demonstration phase or even a first launch before year-end. This depends on management completing engine qualification, structural testing, launch-site work, and full-vehicle integration on schedule, making it a high-execution-risk assumption. The position screenshot shows the OP holding 20 RKLB calls expiring July 24, 2026 with a $100 strike, while selling 1 put expiring June 26, 2026 with a $95 strike. In the screenshot, RKLB’s share price is $85.41, down 10.21% on the day; the options portfolio is worth approximately $7,119.07, with a cost of approximately $9,991.89 and an unrealized loss of approximately $2,872.82. This shows it is a short-dated, out-of-the-money, leveraged, and already pressured upside bet rather than a conservative fundamental valuation analysis. The post does not provide revenue, gross margin, cash burn, backlog discounting, Neutron probability of success, or a target-price model, so its valuation framework is largely missing. The biggest weakness is that successful launches and government missions do support the narrative, but they do not necessarily translate immediately into profits. Rocket Lab still faces high R&D capital expenditure, possible Neutron delays, sentiment shocks from any single failure, a high stock valuation, and time-value decay in near-term options. Another detail is that the OP’s self-made annual mission bar chart shows only 5 missions in 2026, while the official completed-missions list contains more 2026 items, suggesting the image’s statistical scope may be incomplete or stale and cannot be used directly as precise evidence of launch cadence. Overall, this is a catalyst- and narrative-driven bullish RKLB post, mainly betting that the market will reprice Rocket Lab’s defense responsive-launch capability and that Neutron will achieve visible progress within the year.